GlassScriptPhysician profile
Koyenum Chinonso Obi
NPI 1992268320
$6,040.74
in general payments reported to CMS, 2019-2025
27 companies · $1,720 in 2025
The $1,720 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $364 · 2023: $1,136 · 2024: $2,820 · 2025: $1,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,293 · Education: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,293.34 |
| Education | $383.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,022.96 | 2023-2025 | Ensite, Gallant, Cardiomems |
| Novo Nordisk INC | $713.33 | 2024-2025 | Wegovy, Ozempic |
| Amgen INC. | $599.99 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $419.83 | 2024-2025 | Lifevest |
| Abiomed | $404.73 | 2023-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $375.03 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $360.26 | 2022-2025 | Farxiga, Andexxa |
| Pfizer INC. | $345.48 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $301.39 | 2023-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $259.54 | 2023-2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $205.86 | 2024-2025 | Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $178.74 | 2022-2025 | Jardiance |
| Biotronik INC. | $151.02 | 2022-2023 | Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $148.04 | 2022-2025 | Emblem Mri S-Icd, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $113.65 | 2022-2025 | Camzyos, Eliquis |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $111.23 | 2023-2025 | Azure Xt Dr Mri Surescan, Micra, Inceptiv |
| Livanova USA, INC. | $72.43 | 2023 | Tandemlife |
| Biosense Webster, INC. | $61.74 | 2023-2025 | Qdot Micro, Qdot Micro Catheter |
| Actelion Pharmaceuticals US, INC. | $32.65 | 2024 | Uptravi |
| Lexicon Pharmaceuticals, INC. | $28.08 | 2024 | |
| Inari Medical, INC. | $23.93 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lantheus Medical Imaging, INC. | $23.52 | 2022 | |
| Sumitomo Pharma America, INC. | $21.65 | 2025 | Gemtesa |
| Cook Medical LLC | $18.48 | 2023 | Evolution |
| Merck Sharp & Dohme LLC | $16.05 | 2025 | Verquvo |
| Janssen Scientific Affairs, LLC | $15.99 | 2024 | Xarelto |
| Bridgebio Pharma, INC. | $15.14 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Koyenum Obi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.